Article
Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine.
Neuroscience letters - 18 Oct 1996
Arranz M J, Collier D A, Munro J, Sham P, Kirov G, Sodhi M, Roberts G, Price J, Kerwin R W
Abstract excerpt
Clozapine is an atypical antipsychotic with affinity for a broad range of receptors, including serotonin (5-HT) and dopamine receptors. It is successful in treating about 60% of patients refractory to other antipsychotic drugs. Since genetic variation in clozapine's neurotransmitter receptor targets may affect clinical response through altering drug binding or receptor expression, we have studied a His452Tyr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
